03/12/2026
🚨 Peptide Update 🚨
There has been a major regulatory shift: the FDA is in the process of moving several peptides back to Category 1, which may allow compounding pharmacies to produce them again under medical supervision.
While final guidance is still pending, this could reopen access to therapies many patients have been asking about.
At Serenity Mind & Body Solutions, we stay closely aligned with regulatory updates and evidence-based treatments to ensure safe, high-quality care.
✨ Where healing begins and function returns.